Millennial Sisters Develop Potential First Longevity Drug
Originally Published 1 month ago — by The Times
Two young sisters, Carina and Serena Kern-Libera, have founded LinkGevity to develop a pioneering drug targeting necrosis, a key process in ageing, with promising lab results and plans for human trials, aiming to extend healthy lifespan and address age-related diseases.